Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatorycytokines and the p38 MAPK signaling pathway

International Journal of Molecular Medicine

Volumn 30, Issue 1, 2012, Pages 85-92

  Fang, Yan ^a,b   Tian, Xiaohong ^a   Bai, Shuling ^a   Fan, Jun ^a   Hou, Weijian ^a   Tong, Hao ^a   Li, Dehua ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Adipose derived mesenchymal stem cells; Diabetic nephropathy; Oxidative stress; p38 MAPK signaling pathway; Pro inflammatory cytokines

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL;

ADIPOSE DERIVED MESENCHYMAL STEM TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOTRANSPLANTATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; KIDNEY PARENCHYMA; KIDNEY STRUCTURE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CHOLESTEROL; CREATININE; CYTOKINES; DIABETIC NEPHROPATHIES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TRANSPLANTATION, AUTOLOGOUS; TRIGLYCERIDES;

EID: 84861466183     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.977     Document Type: Article

References (38)

1. Dronavalli S, Duka I and Bakris GL: The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4: 444-452, 2008.
2. Kanwar YS, Sun L, Xie P, Liu FY and Chen S: A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6: 395-423, 2011.
3. Kanwar YS, Wada J, Sun L, et al: Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) 233: 4-11, 2008.
4. Soldatos G and Cooper ME: Diabetic nephropathy: important pathophysiologic mechanisms. Diabetes Res Clin Pract 82: S75-S79, 2008.
5. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML and Zelmanovitz T: Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28: 164-176, 2005. (Pubitemid 40095801)
6. Burney BO, Kalaitzidis RG and Bakris GL: Novel therapies of diabetic nephropathy. Curr Opin Nephrol Hypertens 18: 107-111, 2009.
7. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999. (Pubitemid 29282067)
8. Liu ZJ, Zhuge Y and Velazquez OC: Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 106: 984-991, 2009.
9. Ma T: Mesenchymal stem cells: From bench to bedside. World J Stem Cells 2: 13-17, 2010.
10. Locke M, Windsor J and Dunbar PR: Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg 79: 235-244, 2009.
11. Dekel B, Shezen E, Even-Tov-Friedman S, et al: Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells 24: 1185-1193, 2006. (Pubitemid 44464686)
12. Togel F, Weiss K, Yang Y, Hu Z, Zhang P and Westenfelder C: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292: F1626-F1635, 2007. (Pubitemid 46701891)
13. Bi B, Schmitt R, Israilova M, Nishio H and Cantley LG: Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18: 2486-2496, 2007. (Pubitemid 47378865)
14. da Silva LB, Palma PV, Cury PM and Bueno V: Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury. Int Immunopharmacol 7: 1609-1616, 2007. (Pubitemid 350046423)
15. Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL and Duffield JS: Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation 121: 2211-2220, 2010.
16. Liu M and Han ZC: Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy. J Cell Mol Med 12: 1155-1168, 2008.
17. Vanikar AV, Dave SD, Thakkar UG and Trivedi HL: Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus. Stem Cells Int 2010: 582382, 2010.
18. Yang Z, Li K, Yan X, Dong F and Zhao C: Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Graefes Arch Clin Exp Ophthalmol 248: 1415-1422, 2010.
19. Zhang H, Qiu X, Shindel AW, et al: Adipose Tissue-Derived Stem Cells Ameliorate Diabetic Bladder Dysfunction in a Type II Diabetic Rat Model. Stem Cells Dev: October 18, 2011 (Epub ahead of print).
20. Zuk PA, Zhu M, Ashjian P, et al: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295, 2002. (Pubitemid 35471185)
21. Calabrese V, Mancuso C, Sapienza M, et al: Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12: 299-306, 2007.
22. Strem BM, Hicok KC, Zhu M, et al: Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54: 132-141, 2005. (Pubitemid 41542713)
23. Wang L, Deng J, Tian W, et al: Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am J Physiol Heart Circ Physiol 297: H1020-H1031, 2009.
24. Bernardi S, Severini GM, Zauli G and Secchiero P: Cell-based therapies for diabetic complications. Exp Diabetes Res 2012: 872504, 2012.
25. Mitjavila-Garcia MT, Simonin C and Peschanski M: Embryonic stem cells: meeting the needs for cell therapy. Adv Drug Deliv Rev 57: 1935-1943, 2005. (Pubitemid 41682364)
26. Volarevic V, Arsenijevic N, Lukic ML and Stojkovic M: Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 29: 5-10, 2011.
27. Forbes JM, Coughlan MT and Cooper ME: Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446-1454, 2008.
28. Yoh K, Hirayama A, Ishizaki K, et al: Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells 13: 1159-1170, 2008.
29. Navarro JF and Mora C: Role of inflammation in diabetic complications. Nephrol Dial Transplant 20: 2601-2604, 2005. (Pubitemid 41672253)
30. Wolkow PP, Niewczas MA, Perkins B, et al: Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol 19: 789-797, 2008.
31. Matavelli LC, Huang J and Siragy HM: (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation. Clin Exp Pharmacol Physiol 37: 277-282, 2010.
32. Huang J and Siragy HM: Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression. Endocrinology 150: 5557-5565, 2009.
33. Kaul K, Hodgkinson A, Tarr JM, Kohner EM and Chibber R: Is inflammation a common retinal-renal-nerve pathogenic link in diabetes? Curr Diabetes Rev 6: 294-303, 2010.
34. Abdi R, Fiorina P, Adra CN, Atkinson M and Sayegh MH: Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 57: 1759-1767, 2008.
35. Volarevic V, Arsenijevic N, Lukic ML and Stojkovic M: Mesenchymal stem cell treatment of complications of diabetes mellitus. Stem Cells 29: 5-10, 2011.
36. Ono K and Han J: The p38 signal transduction pathway: activation and function. Cell Signal 12: 1-13, 2000. (Pubitemid 30017963)
37. Wilmer WA, Dixon CL and Hebert C: Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. Kidney Int 60: 858-871, 2001. (Pubitemid 34205786)
38. Toyoda M, Suzuki D, Honma M, et al: High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy. Kidney Int 66: 1107-1114, 2004. (Pubitemid 39121016)